FDA Approved: ONDANSETRON — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approved a supplemental application for ondansetron hydrochloride (ONDANSETRON) from Taro Pharmaceuticals U.S.A., Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)